Tsumura & co (4540):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tsumura & co (4540) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10089
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tsumura & co (Tsumura) is a traditional pharmaceutical products company, which undertakes the manufacturing and sale of Kampo extract intermediates and granular Kampo formulations. Its product portfolio includes a range of prescription Kampo products, other pharmaceuticals, over-the-counter (OTC) formulations, Chinese crude drug pieces for decoction and other products. The company provides Kampo products for treating abdominal pain and flatulence, neurosis, insomnia, anorexia, gastritis, maldigestion, cough, bronchitis, bronchial asthma, oversensitivity to cold, menstrual irregularity, climacteric disturbance, leg pain, low back pain, numbness, dysuria, swelling (edema), acute gastroenteritis, common cold, coryza, shoulder stiffness, stomatitis, fermentative diarrhea, neurotic gastritis and other diseases. The company along with its subsidiaries operates in the US, China and Japan. Tsumura is headquartered in Minato-ku, Tokyo, Japan.

Tsumura & co (4540) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tsumura & co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tsumura & co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tsumura & co, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tsumura Forms Joint Venture with Ping An Insurance 10
Tsumura Plans to Form Joint Venture with Tianjin-based Drug Firm 11
Equity Offering 12
Tsumura Raises USD243 Million in Public Offering of Shares 12
Debt Offering 13
Tsumura to Raise USD134.3 Million in Public Offering of 0.23% Bonds Due 2024 13
Tsumura to Raise USD134.3 Million in Public Offering of 0.345% Bonds Due 2027 14
Tsumura & co – Key Competitors 15
Tsumura & co – Key Employees 16
Tsumura & co – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Tsumura & co, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tsumura & co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tsumura & co, Deals By Therapy Area, 2012 to YTD 2018 8
Tsumura & co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tsumura Forms Joint Venture with Ping An Insurance 10
Tsumura Plans to Form Joint Venture with Tianjin-based Drug Firm 11
Tsumura Raises USD243 Million in Public Offering of Shares 12
Tsumura to Raise USD134.3 Million in Public Offering of 0.23% Bonds Due 2024 13
Tsumura to Raise USD134.3 Million in Public Offering of 0.345% Bonds Due 2027 14
Tsumura & co, Key Competitors 15
Tsumura & co, Key Employees 16
Tsumura & co, Other Locations 17
Tsumura & co, Subsidiaries 17

List of Figures
Tsumura & co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tsumura & co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tsumura & co (4540):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Metalloinvest MC LLC:企業の戦略的SWOT分析
    Metalloinvest MC LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Manulife Financial Corporation:企業の戦略・SWOT・財務情報
    Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Manulife Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • W. R. Grace & Co:企業の戦略・SWOT・財務情報
    W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report Summary W. R. Grace & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tractebel Engineering S.A.:企業の戦略的SWOT分析
    Tractebel Engineering S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Dan Hotels Corporation Ltd:戦略・SWOT・企業財務分析
    Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • China Pacific Insurance (Group) Co Ltd:戦略・SWOT・企業財務分析
    China Pacific Insurance (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Pacific Insurance (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務情報
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • American Greetings Corporation (AM):企業の戦略的SWOT分析
    American Greetings Corporation (AM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Keppel Corp Ltd (BN4):石油・ガス:M&Aディール及び事業提携情報
    Summary Keppel Corp Ltd (Keppel) is an investment holding and management company. The Company, through its subsidiaries, carries out operation in the marine, property, infrastructure and telecommunications and transportation businesses. Keppel focuses on offshore oil-rig construction, repair and upg …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務分析
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Sosei Group Corp (4565):製薬・医療:M&Aディール及び事業提携情報
    Summary Sosei Group Corp (Sosei) is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal agent, administered as a muco-adhe …
  • IDFC Ltd (IDFC):企業の財務・戦略的SWOT分析
    IDFC Ltd (IDFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Whirlpool Corp (WHR):企業の財務・戦略的SWOT分析
    Whirlpool Corp (WHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Iproteos SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Iproteos SL (Iproteos) is a biotechnology company that develops therapeutic drugs for human diseases. The company develops drugs to treat various therapeutic indications such as cognitive impairment associated with schizophrenia, epilepsy, paediatric cancer, and others. It provides research …
  • Abu Dhabi National Energy Co (TAQA):企業の財務・戦略的SWOT分析
    Abu Dhabi National Energy Co (TAQA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Hyundai Heavy Industries Co Ltd (009540):電力:M&Aディール及び事業提携情報
    Summary Hyundai Heavy Industries Co Ltd (HHI) is one of the leading shipbuilding companies in the world. HHI manufactures VLCCs, containerships, P/C ships, LNG carriers, and warships. Its offering also includes combined cycle power plant, thermal power plant, oil and gas processing plant, LNG plant, …
  • EVA Airways Corporation:戦略・SWOT・企業財務分析
    EVA Airways Corporation - Strategy, SWOT and Corporate Finance Report Summary EVA Airways Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Pfizer Inc (PFE):企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Desktop Genetics Ltd-医療機器分野:企業M&A・提携分析
    Summary Desktop Genetics Ltd (DeskGen) is a provider of genome editing solutions. The company offers software solutions for the design, synthesis and assembly of DNA. It offers deskgen, which is a software system that helps scientists to organize, optimize, and automate their research. DeskGen’s CRI …
  • Ichor Holdings Ltd (ICHR):企業の財務・戦略的SWOT分析
    Ichor Holdings Ltd (ICHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆